Lipigon Pharmaceuticals AB (OSTO:LPGO) Other Operating Expense : kr15.14 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lipigon Pharmaceuticals AB Other Operating Expense?

Lipigon Pharmaceuticals AB's Other Operating Expense for the three months ended in Dec. 2023 was kr7.79 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was kr15.14 Mil.

Lipigon Pharmaceuticals AB's quarterly Other Operating Expense increased from Jun. 2023 (kr2.12 Mil) to Sep. 2023 (kr5.22 Mil) and increased from Sep. 2023 (kr5.22 Mil) to Dec. 2023 (kr7.79 Mil).

Lipigon Pharmaceuticals AB's annual Other Operating Expense declined from Dec. 2021 (kr6.12 Mil) to Dec. 2022 (kr6.09 Mil) but then increased from Dec. 2022 (kr6.09 Mil) to Dec. 2023 (kr28.78 Mil).

Lipigon Pharmaceuticals AB Other Operating Expense Historical Data

The historical data trend for Lipigon Pharmaceuticals AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipigon Pharmaceuticals AB Other Operating Expense Chart

Lipigon Pharmaceuticals AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

1.27

3.37

6.12

6.09

28.78

Lipigon Pharmaceuticals AB Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial												1.58	1.54	2.12	5.22	7.79

Lipigon Pharmaceuticals AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr15.14 Mil.

Lipigon Pharmaceuticals AB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Lipigon Pharmaceuticals AB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipigon Pharmaceuticals AB (OSTO:LPGO) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

9RP:Germany

Address

Tvistevagen 48 C, Umea, SWE, 90736

Website

https://www.lipigon.se

Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Headlines

No Headlines